This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berger, C. Articles by Schwab, S. Search for Related Content PubMed PubMed Citation Articles by Berger, C. Articles by Schwab, S. Related Collections Brain Circulation and Metabolism Embolic stroke Other Stroke Treatment - Medical

(Stroke. 1999;30:460-463.)
© 1999 American Heart Association, Inc.

Case Report

Neurochemical Monitoring of Fatal Middle Cerebral Artery Infarction

C. Berger, MD; A. Annecke, MD; A. Aschoff, MD; M. Spranger, MD S. Schwab, MD

From the Departments of Neurology (C.B., A. Annecke, M.S., S.S.) and Neurosurgery (A. Aschoff), University of Heidelberg, Heidelberg, Germany.

Correspondence to Stefan Schwab, MD, University of Heidelberg, Department of Neurology, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. E-mail stefan_schwab{at}ukl.uni-heidelberg.de

Background—Microdialysis is a method for neurochemical monitoring that has been applied more frequently over the past few years in patients suffering from subarachnoid hemorrhage, acute brain injury, and stroke. It is used to study the course of extracellular molecules of low molecular weight, such as excitatory amino acids or metabolic end products.

Case Description—We report the case of a 43-year-old patient suffering from left hemispheric stroke with a space-occupying postischemic edema leading to a considerable mass effect on the contralateral side. For treatment of severe edema, hypothermia was initiated. The microdialysis and intracranial pressure probe were placed into the noninfarcted hemisphere. A massive increase in levels of glutamate, glycerine, and the lactate-pyruvate ratio was measured 24 hours before intracranial pressure elevation was observed and brain death occurred.

Conclusions—Monitoring excitatory amino acids, glycerine as a membrane component, and lactate-pyruvate ratio as an energy marker by microdialysis is a useful tool to increase our understanding of biochemical events in secondary brain damage. For future prevention of secondary ischemia in patients with massive stroke, close neurochemical monitoring might be valuable to improve therapy, particularly in the critically ill.

Key Words: cerebral infarction • cerebral ischemia • glutamates • microdialysis • middle cerebral artery

This article has been cited by other articles:

				A. Bhardwaj, B. Bosche, C. Dohmen, and R. Graf In Vivo Regional Neurochemistry in Stroke: Clinical Applications, Limitations, and Future Directions * Cerebral Microdialysis in Stroke Patients: Potentials and Limitations of a Method with Longitudinal Information: Response Stroke, April 1, 2004; 35(4): e74 - e76. [Full Text] [PDF]

				A. S. Sarrafzadeh, D. Haux, L. Ludemann, H. Amthauer, M. Plotkin, I. Kuchler, and A. W. Unterberg Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage: A Correlative Microdialysis-PET Study Stroke, March 1, 2004; 35(3): 638 - 643. [Abstract] [Full Text] [PDF]

				C. Berger and S. Schwab Editorial Comment--"Malignant" or Not: Is There a Role for In Vivo Neurochemistry? Stroke, December 1, 2003; 34(12): 2914 - 2915. [Full Text] [PDF]

				B. Bosche, C. Dohmen, R. Graf, M. Neveling, F. Staub, L. Kracht, J. Sobesky, F.-G. Lehnhardt, and W.-D. Heiss Extracellular Concentrations of Non-Transmitter Amino Acids in Peri-Infarct Tissue of Patients Predict Malignant Middle Cerebral Artery Infarction Stroke, December 1, 2003; 34(12): 2908 - 2913. [Abstract] [Full Text] [PDF]

				C. Dohmen, B. Bosche, R. Graf, F. Staub, L. Kracht, J. Sobesky, M. Neveling, G. Brinker, and W.-D. Heiss Prediction of Malignant Course in MCA Infarction by PET and Microdialysis Stroke, September 1, 2003; 34(9): 2152 - 2158. [Abstract] [Full Text] [PDF]

				W.-R. Schabitz, A. Giuffrida, C. Berger, A. Aschoff, M. Schwaninger, S. Schwab, and D. Piomelli Release of Fatty Acid Amides in a Patient With Hemispheric Stroke: A Microdialysis Study Stroke, August 1, 2002; 33(8): 2112 - 2114. [Abstract] [Full Text] [PDF]

				C. Berger, W.-R. Schabitz, D. Georgiadis, T. Steiner, A. Aschoff, and S. Schwab Effects of Hypothermia on Excitatory Amino Acids and Metabolism in Stroke Patients: A Microdialysis Study Stroke, February 1, 2002; 33(2): 519 - 524. [Abstract] [Full Text] [PDF]

				T. Steiner, J. Pilz, P. Schellinger, R. Wirtz, V. Friederichs, A. Aschoff, and W. Hacke Multimodal Online Monitoring in Middle Cerebral Artery Territory Stroke Stroke, November 1, 2001; 32(11): 2500 - 2506. [Abstract] [Full Text] [PDF]

				S. Schneweis, M. Grond, F. Staub, G. Brinker, M. Neveling, C. Dohmen, R. Graf, W.-D. Heiss, and A. Shuaib Predictive Value of Neurochemical Monitoring in Large Middle Cerebral Artery Infarction Editorial Comment Stroke, August 1, 2001; 32(8): 1863 - 1867. [Abstract] [Full Text] [PDF]

				C. Oppenheim, Y. Samson, R. Manai, T. Lalam, X. Vandamme, S. Crozier, A. Srour, P. Cornu, D. Dormont, G. Rancurel, et al. Prediction of Malignant Middle Cerebral Artery Infarction by Diffusion-Weighted Imaging Stroke, September 1, 2000; 31(9): 2175 - 2181. [Abstract] [Full Text] [PDF]